Trial Profile
A Phase II Trial of Belinostat as Consolidation Therapy With Zidovudine for Adult T-Cell Leukemia-Lymphoma
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 04 Jan 2024
Price :
$35
*
At a glance
- Drugs Belinostat (Primary) ; Zidovudine (Primary) ; Interferon alpha-2b; Peginterferon alfa-2b
- Indications Adult T-cell leukaemia-lymphoma
- Focus Adverse reactions; Therapeutic Use
- 29 Dec 2023 Planned End Date changed from 31 Dec 2024 to 31 Dec 2025.
- 29 Dec 2023 Planned primary completion date changed from 31 Dec 2023 to 31 Dec 2024.
- 25 Apr 2023 Planned number of patients changed from 20 to 10.